Bemipharma(SPRL)

BE 0885.720.658

	2024		2023		2022		2021
Profit/Loss Section 9904: Profit/Loss of the financial year (after taxes on result) (+/-)	€ -564	63%	€ -1.544	40%	€ -2.576	92%	€ -34.293
Equity Section 10/15: Equity consists of capital, capital reserves and earnings that remain within the company. These are fully owned by the company and are at its disposal to cover its risks. The better the ratio between equity and debts, the more solvent a company is. A positive equity ratio is important. A negative equity ratio (because of accumulated losses) is a severe warning sign that the continuity of the company may be threatened.	€ 39.553	-1%	€ 40.117	-4%	€ 41.660	-6%	€ 44.235
Gross margin Section 9900: Gross margin or added value is net sales minus the direct costs of the goods sold. In other words: sales invoices minus purchase invoices (70/74 – 60/61). A negative gross margin is a warning sign especially when occurring over several years. It may indicate that the company has insufficient means to cover internal costs like salaries, etc.	€ -412	70%	€ -1.378	17%	€ -1.650	-4%	€ -1.586
Employees Section 9087: Average number of staff in full time equivalents	0		0		0		0,6

	Date	Publication
	18-01-2021	Registered Office - Resignations, Appointments - Modification Legal Form (FR)
	18-05-2007	Rapport(s) (FR)
	28-12-2006	Constitution (FR)

What is the VAT number of Bemipharma?

The VAT number of Bemipharma is BE0885720658.

When was Bemipharma founded?

Bemipharma was founded on 18-12-2006.

What is the address of Bemipharma?

The current registered office of Bemipharma is located at Rue Amion(FAR) 12, 6240 Farciennes.

When was the last time Bemipharma filed their annual financial statements?

The most recent financial statements of Bemipharma were filed on 19-05-2025. You can view them here.

How many employees does Bemipharma have?

There are 1 FTEs working at Bemipharma according to the staff figures in the most recent financial statements.

What is the annual turnover of Bemipharma?

At the time of its most recent financial statements, Bemipharma did not publish any turnover figures. Bemipharma reported a gross margin of -€411.88.